Maxwell L Van Tassell - FDA Investigator Report
Total Inspections: 9
Total 483s Issued: 8
Total Warning Letters Issued: 0
Inspection Details
Longest Inspection: 9 days
Shortest Inspection: 5 days
Average Length of Inspection: 8.1 days
Discover the bigger picture. This is just the tip of the iceberg.
Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.
Schedule a DemoMaxwell L Van Tassell's - Recent Inspections
Date | Company | City | Country | FEI Number | 483 |
---|
2019-10-08 | Astellas Pharma Inc. | Toyama | Japan | 3002807003 | |
2019-08-29 | Novartis Pharma AG | Basel | Switzerland | 3002807772 | |
2019-05-08 | Amgen Manufacturing Ltd | Juncos | United States | 1000110364 | |
2019-01-18 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Andover | United States | 1222181 | |
2018-06-08 | Regeneron Pharmaceuticals Inc | Rensselaer | United States | 1000514603 | |
2018-04-24 | Dompe Farmaceutici S.p.A. | L'Aquila | Italy | 3004216297 | |
2018-02-20 | Hospira Zagreb d.o.o. | Brdovec | Croatia | 3010630287 | |
2017-09-27 | Chugai Pharmaceutical Co., Ltd. | Kita | Japan | 3002926698 | |
2017-05-23 | Rentschler Biopharma SE | Laupheim | Germany | 1000291122 | |
Maxwell L Van Tassell - Co-Inspectors
Maxwell L Van Tassell's - Active Locations
- United States
- Japan
- Italy
- Switzerland
- Germany
- Croatia
Maxwell L Van Tassell's - Year-wise Inspection Count
- 2017: 2 inspections
- 2018: 3 inspections
- 2019: 4 inspections
Last Updated: 2025-05-14 06:11:22